Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Putti

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2005
Early cerebral sinovenous thrombosis in a child with acute lymphoblastic leukemia carrying the prothrombin G20210A variant: a case report and review of the literatureStefano Mazzoleni, Maria C Putti, Paolo Simioni, et al.
Mycoses|February 12, 2009
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approachSimone Cesaro, Serena Marinello, Bellan Alessia, et al.
British Journal of Haematology|July 31, 2015
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trialPaola Quarello, Franca Fagioli, Giuseppe Basso, et al.
Pharmaceutical Research|November 12, 2015
Model-Based Optimisation of Deferoxamine Chelation TherapyFrancesco Bellanti, Giovanni C Del Vecchio, Maria C Putti, et al.
British Journal of Haematology|September 30, 2017
A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemiaMatteo Zampini, Valeria Bisio, Anna Leszl, et al.
Haematologica|October 29, 2017
Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety studySebastian Botzenhardt, Mariagrazia Felisi, Donato Bonifazi, et al.
Leukemia & Lymphoma|July 17, 2012
Psychosocial life achievements in adults even if they received prophylactic cranial irradiation for acute lymphoblastic leukemia during childhoodMarta Pillon, Gloria Tridello, Maria P Boaro, et al.
British Journal of Clinical Pharmacology|September 20, 2016
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 yearsFrancesco Bellanti, Giovanni C Del Vecchio, Maria C Putti, et al.
Pediatric Blood & Cancer|June 29, 2019
Predictors of mortality after admission to pediatric intensive care unit in oncohematologic patients without history of hematopoietic stem cell transplantation: A single-center experienceMarta Pillon, Francesca Sperotto, Emma Zattarin, et al.
British Journal of Haematology|July 21, 2018
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemiaLuisa Strocchio, Carmelo Gurnari, Nicola Santoro, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2005
Early cerebral sinovenous thrombosis in a child with acute lymphoblastic leukemia carrying the prothrombin G20210A variant: a case report and review of the literatureStefano Mazzoleni, Maria C Putti, Paolo Simioni, et al.
Mycoses|February 12, 2009
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approachSimone Cesaro, Serena Marinello, Bellan Alessia, et al.
British Journal of Haematology|July 31, 2015
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trialPaola Quarello, Franca Fagioli, Giuseppe Basso, et al.
Pharmaceutical Research|November 12, 2015
Model-Based Optimisation of Deferoxamine Chelation TherapyFrancesco Bellanti, Giovanni C Del Vecchio, Maria C Putti, et al.
British Journal of Haematology|September 30, 2017
A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemiaMatteo Zampini, Valeria Bisio, Anna Leszl, et al.
Haematologica|October 29, 2017
Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety studySebastian Botzenhardt, Mariagrazia Felisi, Donato Bonifazi, et al.
Leukemia & Lymphoma|July 17, 2012
Psychosocial life achievements in adults even if they received prophylactic cranial irradiation for acute lymphoblastic leukemia during childhoodMarta Pillon, Gloria Tridello, Maria P Boaro, et al.
British Journal of Clinical Pharmacology|September 20, 2016
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 yearsFrancesco Bellanti, Giovanni C Del Vecchio, Maria C Putti, et al.
Pediatric Blood & Cancer|June 29, 2019
Predictors of mortality after admission to pediatric intensive care unit in oncohematologic patients without history of hematopoietic stem cell transplantation: A single-center experienceMarta Pillon, Francesca Sperotto, Emma Zattarin, et al.
British Journal of Haematology|July 21, 2018
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemiaLuisa Strocchio, Carmelo Gurnari, Nicola Santoro, et al.
Pageof 3